. . . . . . . . . . . . "a(SCHEM:GW501516) -> r(HGNC:PDK4)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "Incubation of differentiated human myotubes for 18 h with GW501516 resulted in a significant increase in CPT1 (5.5-fold), PDK4 (4-fold), and FABP3 (1.7-fold) expression compared with vehicle-treated cells (Fig. 3A). The GW501516-mediated transcriptional effect on CPT1, PDK4, and FABP3 was abolished when PPARd expression was reduced using siRNA." . . "Selventa" . . . . "2014-07-03T14:33:10.568+02:00"^^ . . .